-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
-
Summary
-
Regencell Bioscience Holdings Ltd quarterly Assets, Current history and growth rate from Q2 2020 to Q2 2024.
- Regencell Bioscience Holdings Ltd Assets, Current for the quarter ending June 30, 2024 was $8.11M, a 30.2% decline year-over-year.
Assets, Current, Quarterly (USD)
Assets, Current, YoY Quarterly Growth (%)